Handelsbanken Fonder Ab Immunome Inc. Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
A detailed history of Handelsbanken Fonder Ab transactions in Immunome Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 200,000 shares of IMNM stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200,000
Previous 230,000
13.04%
Holding current value
$1.87 Million
Previous $3.36 Million
36.84%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IMNM
# of Institutions
124Shares Held
45.4MCall Options Held
38.7KPut Options Held
2.05M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$51.4 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$45.1 Million3.87% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$36.2 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$35.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.46MShares$32.3 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $113M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...